Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
19 Feb 2024 |
CH01 |
Director's details changed for Ms Seyda Atadan Memis on 1 September 2023
|
|
|
04 Sep 2023 |
SH19 |
Statement of capital on 4 September 2023
|
|
|
04 Sep 2023 |
SH20 |
Statement by Directors
|
|
|
04 Sep 2023 |
CAP-SS |
Solvency Statement dated 04/09/23
|
|
|
04 Sep 2023 |
RESOLUTIONS |
Resolutions
-
RES06 ‐
Resolution of reduction in issued share capital
-
RES13 ‐
Cancel share prem a/cand capital redemption reserve 04/09/2023
|
|
|
23 Aug 2023 |
CS01 |
Confirmation statement made on 20 August 2023 with no updates
|
|
|
26 Jan 2023 |
TM01 |
Termination of appointment of Jonathan Clark Neal as a director on 18 January 2023
|
|
|
22 Dec 2022 |
AA |
Accounts for a small company made up to 31 March 2022
|
|
|
10 Nov 2022 |
TM01 |
Termination of appointment of Mark Gibbons as a director on 8 November 2022
|
|
|
26 Aug 2022 |
CS01 |
Confirmation statement made on 20 August 2022 with updates
|
|
|
23 Aug 2022 |
AP01 |
Appointment of Ms Seyda Atadan Memis as a director on 1 August 2022
|
|
|
22 Aug 2022 |
SH10 |
Particulars of variation of rights attached to shares
|
|
|
18 Aug 2022 |
PSC02 |
Notification of Gammadelta Therapeutics Ltd as a person with significant control on 1 August 2022
|
|
|
18 Aug 2022 |
PSC07 |
Cessation of Takeda Pharmaceutical Company Limited as a person with significant control on 1 August 2022
|
|
|
11 Aug 2022 |
RESOLUTIONS |
Resolutions
-
RES10 ‐
Resolution of allotment of securities
-
RES13 ‐
Company business 01/08/2022
-
RES01 ‐
Resolution of adoption of Articles of Association
|
|
|
11 Aug 2022 |
MA |
Memorandum and Articles of Association
|
|
|
10 Aug 2022 |
MR04 |
Satisfaction of charge 121667870001 in full
|
|
|
05 May 2022 |
SH01 |
Statement of capital following an allotment of shares on 26 April 2022
|
|
|
02 May 2022 |
PSC05 |
Change of details for Takeda Pharmaceutical Company Limited as a person with significant control on 26 April 2022
|
|
|
02 May 2022 |
PSC07 |
Cessation of Abingworth Llp as a person with significant control on 26 April 2022
|
|
|
29 Apr 2022 |
AD01 |
Registered office address changed from Westworks 195 Wood Lane White City Place London W12 7FQ England to 1 Kingdom Street London W2 6BD on 29 April 2022
|
|
|
27 Apr 2022 |
AP01 |
Appointment of Mr Jonathan Clark Neal as a director on 26 April 2022
|
|
|
27 Apr 2022 |
AP01 |
Appointment of Dr Emma Jane Roffe as a director on 26 April 2022
|
|
|
26 Apr 2022 |
TM01 |
Termination of appointment of Christine Kim Ward as a director on 26 April 2022
|
|
|
26 Apr 2022 |
TM01 |
Termination of appointment of John Gerard Shields as a director on 26 April 2022
|
|